The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma.
Article in Cancer Letters (May 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Cancer Letters (May 2024)
Article in Heliyon (November 2023)
Article in Biomedicine & Pharmacotherapy (April 2023)